心身症状量表在抑郁发作患者中的临床应用研究  

Clinical application of Psychosomatic Symptom Scale in patients with depressive episode

作　　者：游林林 李磊 陈青松[3] 杨忠[4] 潘惠[4] 王明[4] 胡长春[5] 沈仲夏[6] 吴江[2] 袁勇贵[1] YOU Linlin;LI Lei;CHEN Qingsong;YANG Zhong;PAN Hui;WANG Ming;HU Changchun;SHEN Zhongxia;WU Jiang;YUAN Yonggui(Department of Psychiatry, Zhongda Hospital, Southeast University, Nanjing 210009, China;The Fourth People's Hospital of Lianyungang, Lianyungang 222023, China;The Second People's Hospital of Jingjiang, Jingjiang 214500, China;The Third People's Hospital of Changshu, Changshu 215501, China;Department of Psychiatry, Hangzhou First People's Hospital, Hangzhou 310000, China;Department of Psychiatry, Huzhou Third People's Hospital, Huzhou 313000, China)

机构地区：[1]东南大学附属中大医院心理精神科,江苏南京210009 [2]连云港市第四人民医院,江苏连云港222023 [3]靖江市第二人民医院,江苏靖江214500 [4]常熟市第三人民医院,江苏常熟215501 [5]杭州市第一人民医院精神科,浙江杭州310000 [6]湖州市第三人民医院精神科,浙江湖州313000

出　　处：《东南大学学报（医学版）》2022年第3期439-443,共5页Journal of Southeast University(Medical Science Edition)

摘　　要：目的:使用心身症状量表(PSSS)、9条目患者健康问卷(PHQ-9)、广泛性焦虑障碍量表(GAD-7)及患者健康问卷躯体症状群量表(PHQ-15)同时评估抑郁发作患者,以探讨PSSS评估抑郁、焦虑和心身症状的效能。方法:选取193例抑郁发作患者,分别于入组当天及2周末采用PSSS、PHQ-9、GAD-7及PHQ-15评估抑郁、焦虑及心身症状,将治疗前后各量表因子分及2周减分率进行Pearson相关分析,评价PSSS与其他量表的等效性。结果:治疗前后,PSSS评分与PHQ-9、GAD-7、PHQ-15评分均呈显著正相关(均r>0,P<0.001);PSSS评分减分率与PHQ-9、GAD-7及PHQ-15评分减分率也均呈显著正相关(均r>0,P<0.001);PSSS与PHQ-9、GAD-7、PHQ-15评估抑郁、焦虑及心身症状的治疗有效性(减分率≥50%)相比,差异均无统计学意义(均P>0.05)。结论:PSSS可有效评估抑郁发作患者的抑郁、焦虑和心身症状的严重程度,并可作为疗效的评价工具。Objective:To use the Psychosomatic Symptoms Scale(PSSS),the 9-item Patient Health Questionnaire(PHQ-9),the Generalized Anxiety Disorder Scale(GAD-7),and the Patient Health Questionnaire Somatic Symptoms Group Scale(PHQ-15)to evaluate patients with depressive episode to explore the efficacy of PSSS in assessing depression,anxiety,and psychosomatic symptoms.Methods:A total of 193 patients with depressive episode were selected.The depressive symptoms,anxiety symptoms and somatic symptom were assessed by PSSS,PHQ-9,GAD-7 and PHQ-15 on the enrollment day and 2 weekends,respectively.Pearson correlation analysis was performed on the score of each scale and 2-week reduction rate before and after treatment to evaluate the equivalence between PSSS and other scales.Results:Before and after treatment,PSSS scores were significantly positively correlated with PHQ-9,GAD-7 and PHQ-15 scores(P<0.001);There was a significant positive correlation between the reduction rate of PSSS scores and PHQ-9,GAD-7 and PHQ-15 scores(P<0.001);Compared with PHQ-9,GAD-7 and PHQ-15 in the evaluation of the efficacy of depression,anxiety and somatic symptoms(reduction rate≥50%),there was no statistical significance in PSSS(P>0.05).Conclusion:The PSSS can be used as a tool to evaluate the severity of depression,anxiety and psychosomatic symptoms in patients with depressive episode.

关 键 词：抑郁发作 心身症状量表 抑郁 焦虑 躯体症状 

分 类 号：R749.41[医药卫生—神经病学与精神病学]